The global Pharmaceutical outsourcing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Pharmaceutical outsourcing has evolved from basic processes, namely bottling, to more added value techniques such as medical device engineering or R&D (research and development).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report includes an overview of the development of the Pharmaceutical outsourcing industry chain, the market status of Drug Discovery (Raw Material Sourcing, Active Pharmaceutical Ingredient), Clinical Trials (Raw Material Sourcing, Active Pharmaceutical Ingredient), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pharmaceutical outsourcing.
Regionally, the report analyzes the Pharmaceutical outsourcing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pharmaceutical outsourcing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pharmaceutical outsourcing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pharmaceutical outsourcing industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Raw Material Sourcing, Active Pharmaceutical Ingredient).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pharmaceutical outsourcing market.
Regional Analysis: The report involves examining the Pharmaceutical outsourcing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pharmaceutical outsourcing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pharmaceutical outsourcing:
Company Analysis: Report covers individual Pharmaceutical outsourcing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pharmaceutical outsourcing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Drug Discovery, Clinical Trials).
Technology Analysis: Report covers specific technologies relevant to Pharmaceutical outsourcing. It assesses the current state, advancements, and potential future developments in Pharmaceutical outsourcing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pharmaceutical outsourcing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Pharmaceutical outsourcing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Raw Material Sourcing
Active Pharmaceutical Ingredient
Finished Drugs
麻豆原创 segment by Application
Drug Discovery
Clinical Trials
Pre-Clinical Development
Biology Research
麻豆原创 segment by players, this report covers
ABC Laboratories
Aenova
Alkermes
Associates of Cape Cod
BioPharma Solutions
Catalent Pharma Solutions
Coldstream Laboratories
Covance
Cytovance Biologics
Dalton Pharma Services
DPT Laboratories
Emergent BioSolutions
Fresenius Kabi
Grand River Aseptic Manufacturing
Halo Pharmaceutical
IGI Laboratories
Lyophilization Technology
Metrics
Mikart
Patheon
Pillar5 Pharma
Velesco Pharma
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical outsourcing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical outsourcing, with revenue, gross margin and global market share of Pharmaceutical outsourcing from 2019 to 2024.
Chapter 3, the Pharmaceutical outsourcing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pharmaceutical outsourcing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical outsourcing.
Chapter 13, to describe Pharmaceutical outsourcing research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Pharmaceutical outsourcing
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical outsourcing by Type
1.3.1 Overview: Global Pharmaceutical outsourcing 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Pharmaceutical outsourcing Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Raw Material Sourcing
1.3.4 Active Pharmaceutical Ingredient
1.3.5 Finished Drugs
1.4 Global Pharmaceutical outsourcing 麻豆原创 by Application
1.4.1 Overview: Global Pharmaceutical outsourcing 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Drug Discovery
1.4.3 Clinical Trials
1.4.4 Pre-Clinical Development
1.4.5 Biology Research
1.5 Global Pharmaceutical outsourcing 麻豆原创 Size & Forecast
1.6 Global Pharmaceutical outsourcing 麻豆原创 Size and Forecast by Region
1.6.1 Global Pharmaceutical outsourcing 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Pharmaceutical outsourcing 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Pharmaceutical outsourcing 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Pharmaceutical outsourcing 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Pharmaceutical outsourcing 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Pharmaceutical outsourcing 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Pharmaceutical outsourcing 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 ABC Laboratories
2.1.1 ABC Laboratories Details
2.1.2 ABC Laboratories Major Business
2.1.3 ABC Laboratories Pharmaceutical outsourcing Product and Solutions
2.1.4 ABC Laboratories Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 ABC Laboratories Recent Developments and Future Plans
2.2 Aenova
2.2.1 Aenova Details
2.2.2 Aenova Major Business
2.2.3 Aenova Pharmaceutical outsourcing Product and Solutions
2.2.4 Aenova Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Aenova Recent Developments and Future Plans
2.3 Alkermes
2.3.1 Alkermes Details
2.3.2 Alkermes Major Business
2.3.3 Alkermes Pharmaceutical outsourcing Product and Solutions
2.3.4 Alkermes Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Alkermes Recent Developments and Future Plans
2.4 Associates of Cape Cod
2.4.1 Associates of Cape Cod Details
2.4.2 Associates of Cape Cod Major Business
2.4.3 Associates of Cape Cod Pharmaceutical outsourcing Product and Solutions
2.4.4 Associates of Cape Cod Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Associates of Cape Cod Recent Developments and Future Plans
2.5 BioPharma Solutions
2.5.1 BioPharma Solutions Details
2.5.2 BioPharma Solutions Major Business
2.5.3 BioPharma Solutions Pharmaceutical outsourcing Product and Solutions
2.5.4 BioPharma Solutions Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 BioPharma Solutions Recent Developments and Future Plans
2.6 Catalent Pharma Solutions
2.6.1 Catalent Pharma Solutions Details
2.6.2 Catalent Pharma Solutions Major Business
2.6.3 Catalent Pharma Solutions Pharmaceutical outsourcing Product and Solutions
2.6.4 Catalent Pharma Solutions Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Catalent Pharma Solutions Recent Developments and Future Plans
2.7 Coldstream Laboratories
2.7.1 Coldstream Laboratories Details
2.7.2 Coldstream Laboratories Major Business
2.7.3 Coldstream Laboratories Pharmaceutical outsourcing Product and Solutions
2.7.4 Coldstream Laboratories Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Coldstream Laboratories Recent Developments and Future Plans
2.8 Covance
2.8.1 Covance Details
2.8.2 Covance Major Business
2.8.3 Covance Pharmaceutical outsourcing Product and Solutions
2.8.4 Covance Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Covance Recent Developments and Future Plans
2.9 Cytovance Biologics
2.9.1 Cytovance Biologics Details
2.9.2 Cytovance Biologics Major Business
2.9.3 Cytovance Biologics Pharmaceutical outsourcing Product and Solutions
2.9.4 Cytovance Biologics Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Cytovance Biologics Recent Developments and Future Plans
2.10 Dalton Pharma Services
2.10.1 Dalton Pharma Services Details
2.10.2 Dalton Pharma Services Major Business
2.10.3 Dalton Pharma Services Pharmaceutical outsourcing Product and Solutions
2.10.4 Dalton Pharma Services Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Dalton Pharma Services Recent Developments and Future Plans
2.11 DPT Laboratories
2.11.1 DPT Laboratories Details
2.11.2 DPT Laboratories Major Business
2.11.3 DPT Laboratories Pharmaceutical outsourcing Product and Solutions
2.11.4 DPT Laboratories Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 DPT Laboratories Recent Developments and Future Plans
2.12 Emergent BioSolutions
2.12.1 Emergent BioSolutions Details
2.12.2 Emergent BioSolutions Major Business
2.12.3 Emergent BioSolutions Pharmaceutical outsourcing Product and Solutions
2.12.4 Emergent BioSolutions Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Emergent BioSolutions Recent Developments and Future Plans
2.13 Fresenius Kabi
2.13.1 Fresenius Kabi Details
2.13.2 Fresenius Kabi Major Business
2.13.3 Fresenius Kabi Pharmaceutical outsourcing Product and Solutions
2.13.4 Fresenius Kabi Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Fresenius Kabi Recent Developments and Future Plans
2.14 Grand River Aseptic Manufacturing
2.14.1 Grand River Aseptic Manufacturing Details
2.14.2 Grand River Aseptic Manufacturing Major Business
2.14.3 Grand River Aseptic Manufacturing Pharmaceutical outsourcing Product and Solutions
2.14.4 Grand River Aseptic Manufacturing Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Grand River Aseptic Manufacturing Recent Developments and Future Plans
2.15 Halo Pharmaceutical
2.15.1 Halo Pharmaceutical Details
2.15.2 Halo Pharmaceutical Major Business
2.15.3 Halo Pharmaceutical Pharmaceutical outsourcing Product and Solutions
2.15.4 Halo Pharmaceutical Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Halo Pharmaceutical Recent Developments and Future Plans
2.16 IGI Laboratories
2.16.1 IGI Laboratories Details
2.16.2 IGI Laboratories Major Business
2.16.3 IGI Laboratories Pharmaceutical outsourcing Product and Solutions
2.16.4 IGI Laboratories Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 IGI Laboratories Recent Developments and Future Plans
2.17 Lyophilization Technology
2.17.1 Lyophilization Technology Details
2.17.2 Lyophilization Technology Major Business
2.17.3 Lyophilization Technology Pharmaceutical outsourcing Product and Solutions
2.17.4 Lyophilization Technology Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Lyophilization Technology Recent Developments and Future Plans
2.18 Metrics
2.18.1 Metrics Details
2.18.2 Metrics Major Business
2.18.3 Metrics Pharmaceutical outsourcing Product and Solutions
2.18.4 Metrics Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 Metrics Recent Developments and Future Plans
2.19 Mikart
2.19.1 Mikart Details
2.19.2 Mikart Major Business
2.19.3 Mikart Pharmaceutical outsourcing Product and Solutions
2.19.4 Mikart Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.19.5 Mikart Recent Developments and Future Plans
2.20 Patheon
2.20.1 Patheon Details
2.20.2 Patheon Major Business
2.20.3 Patheon Pharmaceutical outsourcing Product and Solutions
2.20.4 Patheon Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.20.5 Patheon Recent Developments and Future Plans
2.21 Pillar5 Pharma
2.21.1 Pillar5 Pharma Details
2.21.2 Pillar5 Pharma Major Business
2.21.3 Pillar5 Pharma Pharmaceutical outsourcing Product and Solutions
2.21.4 Pillar5 Pharma Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.21.5 Pillar5 Pharma Recent Developments and Future Plans
2.22 Velesco Pharma
2.22.1 Velesco Pharma Details
2.22.2 Velesco Pharma Major Business
2.22.3 Velesco Pharma Pharmaceutical outsourcing Product and Solutions
2.22.4 Velesco Pharma Pharmaceutical outsourcing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.22.5 Velesco Pharma Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Pharmaceutical outsourcing Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Pharmaceutical outsourcing by Company Revenue
3.2.2 Top 3 Pharmaceutical outsourcing Players 麻豆原创 Share in 2023
3.2.3 Top 6 Pharmaceutical outsourcing Players 麻豆原创 Share in 2023
3.3 Pharmaceutical outsourcing 麻豆原创: Overall Company Footprint Analysis
3.3.1 Pharmaceutical outsourcing 麻豆原创: Region Footprint
3.3.2 Pharmaceutical outsourcing 麻豆原创: Company Product Type Footprint
3.3.3 Pharmaceutical outsourcing 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Pharmaceutical outsourcing Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Pharmaceutical outsourcing 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Pharmaceutical outsourcing Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Pharmaceutical outsourcing 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical outsourcing Consumption Value by Type (2019-2030)
6.2 North America Pharmaceutical outsourcing Consumption Value by Application (2019-2030)
6.3 North America Pharmaceutical outsourcing 麻豆原创 Size by Country
6.3.1 North America Pharmaceutical outsourcing Consumption Value by Country (2019-2030)
6.3.2 United States Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Pharmaceutical outsourcing Consumption Value by Type (2019-2030)
7.2 Europe Pharmaceutical outsourcing Consumption Value by Application (2019-2030)
7.3 Europe Pharmaceutical outsourcing 麻豆原创 Size by Country
7.3.1 Europe Pharmaceutical outsourcing Consumption Value by Country (2019-2030)
7.3.2 Germany Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical outsourcing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Pharmaceutical outsourcing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Pharmaceutical outsourcing 麻豆原创 Size by Region
8.3.1 Asia-Pacific Pharmaceutical outsourcing Consumption Value by Region (2019-2030)
8.3.2 China Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Pharmaceutical outsourcing Consumption Value by Type (2019-2030)
9.2 South America Pharmaceutical outsourcing Consumption Value by Application (2019-2030)
9.3 South America Pharmaceutical outsourcing 麻豆原创 Size by Country
9.3.1 South America Pharmaceutical outsourcing Consumption Value by Country (2019-2030)
9.3.2 Brazil Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical outsourcing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Pharmaceutical outsourcing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Pharmaceutical outsourcing 麻豆原创 Size by Country
10.3.1 Middle East & Africa Pharmaceutical outsourcing Consumption Value by Country (2019-2030)
10.3.2 Turkey Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Pharmaceutical outsourcing 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Pharmaceutical outsourcing 麻豆原创 Drivers
11.2 Pharmaceutical outsourcing 麻豆原创 Restraints
11.3 Pharmaceutical outsourcing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Pharmaceutical outsourcing Industry Chain
12.2 Pharmaceutical outsourcing Upstream Analysis
12.3 Pharmaceutical outsourcing Midstream Analysis
12.4 Pharmaceutical outsourcing Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
ABC Laboratories
Aenova
Alkermes
Associates of Cape Cod
BioPharma Solutions
Catalent Pharma Solutions
Coldstream Laboratories
Covance
Cytovance Biologics
Dalton Pharma Services
DPT Laboratories
Emergent BioSolutions
Fresenius Kabi
Grand River Aseptic Manufacturing
Halo Pharmaceutical
IGI Laboratories
Lyophilization Technology
Metrics
Mikart
Patheon
Pillar5 Pharma
Velesco Pharma
听
听
*If Applicable.
